|Articles|May 2, 2017
WIRB-Copernicus Group Acquires ThreeWire
WIRB-Copernicus Group announces the acquisition of ThreeWire.
Advertisement
WIRB-Copernicus Group announces the acquisition of ThreeWire, a global patient recruitment, enrollment and retention firm that assists biopharma, medical device companies and CROs achieve trial enrollment and retention goals.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
Targeted and Strategy-Driven Clinical Development
3
ACT Brief: FDA’s Agentic AI Rollout, Exercise Interventions for Long COVID, and Patient-Centered Evidence Beyond the Trial
4
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
